Literature DB >> 10784587

Intestinal inflammation observed in IL-2R/IL-2 mutant mice is associated with impaired intestinal T lymphopoiesis.

P Poussier1, T Ning, J Chen, D Banerjee, M Julius.   

Abstract

BACKGROUND & AIMS: Although interleukin (IL)-2(-/-) and IL-2Ralpha(-/-) mice develop inflammatory bowel disease, IL-2Rbeta(-/-) animals are apparently free of gut pathology. Intraintestinal T lymphopoiesis is reported to be impaired in IL-2Rbeta(-/-) mice; we have determined whether this characteristic correlated with the apparent resistance of this mutant strain to intestinal inflammation. This led us to reassess intraintestinal T lymphopoiesis in these 3 mutant strains.
METHODS: Intestinal histology and intraintestinal T lymphopoiesis were analyzed in unmanipulated mutant mice and in athymic and euthymic radiation chimeras reconstituted with bone marrow derived from IL-2(-/-), IL-2Ralpha(-/-), and IL-2Rbeta(-/-) donors.
RESULTS: Intraintestinal T lymphopoiesis was ablated in the 3 mutant strains and was associated with cryptopatch abnormalities. The intestinal mucosa of mice reconstituted with lymphocytes from IL-2Rbeta(-/-) mice exhibited lesions of both the small and large bowel similar to those observed in the early stages of human gluten enteropathy and acute ulcerative colitis, respectively. Analysis of euthymic and athymic bone marrow radiation chimeras indicated that T cells located in the intestinal mucosa of unmanipulated IL-2(-/-), IL-2Ralpha(-/-), and IL-2Rbeta(-/-) mice are of thymic origin.
CONCLUSIONS: Null mutations at IL-2/IL-2Ralpha and beta loci differentially affect intraintestinal and intrathymic T lymphopoiesis. These conditions are associated with lesions of intestinal inflammation that are mediated by thymus-derived T cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10784587     DOI: 10.1016/s0016-5085(00)70174-0

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  13 in total

Review 1.  Role of regulatory T cell in the pathogenesis of inflammatory bowel disease.

Authors:  Akiko Yamada; Rieko Arakaki; Masako Saito; Takaaki Tsunematsu; Yasusei Kudo; Naozumi Ishimaru
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 2.  Role of helminths in regulating mucosal inflammation.

Authors:  Joel V Weinstock; Robert W Summers; David E Elliott
Journal:  Springer Semin Immunopathol       Date:  2005-06-15

3.  Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial.

Authors:  G Van Assche; W J Sandborn; B G Feagan; B A Salzberg; D Silvers; P S Monroe; W M Pandak; F H Anderson; J F Valentine; G E Wild; D J Geenen; R Sprague; S R Targan; P Rutgeerts; V Vexler; D Young; R S Shames
Journal:  Gut       Date:  2006-04-07       Impact factor: 23.059

Review 4.  Genetically engineered mouse models for studying inflammatory bowel disease.

Authors:  Atsushi Mizoguchi; Takahito Takeuchi; Hidetomo Himuro; Toshiyuki Okada; Emiko Mizoguchi
Journal:  J Pathol       Date:  2015-11-14       Impact factor: 7.996

5.  An important regulatory role for CD4+CD8 alpha alpha T cells in the intestinal epithelial layer in the prevention of inflammatory bowel disease.

Authors:  Gobardhan Das; Mathew M Augustine; Jyoti Das; Kim Bottomly; Prabir Ray; Anuradha Ray
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-14       Impact factor: 11.205

6.  The juvenile alopecia mutation (jal) maps to mouse Chromosome 2, and is an allele of GATA binding protein 3 (Gata3).

Authors:  Francisco Ramirez; Aaron M Feliciano; Elisabeth B Adkins; Kevin M Child; Legairre A Radden; Alexis Salas; Nelson Vila-Santana; José M Horák; Samantha R Hughes; Damek V Spacek; Thomas R King
Journal:  BMC Genet       Date:  2013-05-09       Impact factor: 2.797

7.  A unique subset of self-specific intraintestinal T cells maintains gut integrity.

Authors:  Philippe Poussier; Terri Ning; Diponkar Banerjee; Michael Julius
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

8.  Resident skin-specific gammadelta T cells provide local, nonredundant regulation of cutaneous inflammation.

Authors:  Michael Girardi; Julia Lewis; Earl Glusac; Renata B Filler; Liping Geng; Adrian C Hayday; Robert E Tigelaar
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

9.  Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®.

Authors:  Anne-Kristin Heninger; Sabine Wentrup; Mohammed Al-Saeedi; Serin Schiessling; Thomas Giese; Florian Wartha; Stefan Meuer; Jutta Schröder-Braunstein
Journal:  Immun Inflamm Dis       Date:  2014-11-03

10.  Aberrant extrathymic T cell receptor gene rearrangement in the small intestinal mucosa: a risk factor for coeliac disease?

Authors:  A Bas; G Forsberg; V Sjöberg; S Hammarström; O Hernell; M-L Hammarström
Journal:  Gut       Date:  2008-02-25       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.